200 related articles for article (PubMed ID: 17704059)
1. Role of ADAM-9 disintegrin-cysteine-rich domains in human keratinocyte migration.
Zigrino P; Steiger J; Fox JW; Löffek S; Schild A; Nischt R; Mauch C
J Biol Chem; 2007 Oct; 282(42):30785-93. PubMed ID: 17704059
[TBL] [Abstract][Full Text] [Related]
2. The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts.
Zigrino P; Nischt R; Mauch C
J Biol Chem; 2011 Feb; 286(8):6801-7. PubMed ID: 21135106
[TBL] [Abstract][Full Text] [Related]
3. The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading.
Iba K; Albrechtsen R; Gilpin B; Fröhlich C; Loechel F; Zolkiewska A; Ishiguro K; Kojima T; Liu W; Langford JK; Sanderson RD; Brakebusch C; Fässler R; Wewer UM
J Cell Biol; 2000 May; 149(5):1143-56. PubMed ID: 10831617
[TBL] [Abstract][Full Text] [Related]
4. Sequence-specific interaction between the disintegrin domain of mouse ADAM 3 and murine eggs: role of beta1 integrin-associated proteins CD9, CD81, and CD98.
Takahashi Y; Bigler D; Ito Y; White JM
Mol Biol Cell; 2001 Apr; 12(4):809-20. PubMed ID: 11294888
[TBL] [Abstract][Full Text] [Related]
5. Role of multiple beta1 integrins in cell adhesion to the disintegrin domains of ADAMs 2 and 3.
Tomczuk M; Takahashi Y; Huang J; Murase S; Mistretta M; Klaffky E; Sutherland A; Bolling L; Coonrod S; Marcinkiewicz C; Sheppard D; Stepp MA; White JM
Exp Cell Res; 2003 Oct; 290(1):68-81. PubMed ID: 14516789
[TBL] [Abstract][Full Text] [Related]
6. Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain.
Zolkiewska A
Exp Cell Res; 1999 Nov; 252(2):423-31. PubMed ID: 10527632
[TBL] [Abstract][Full Text] [Related]
7. Meltrin gamma(ADAM-9) mediates cellular adhesion through alpha(6)beta(1 )integrin, leading to a marked induction of fibroblast cell motility.
Nath D; Slocombe PM; Webster A; Stephens PE; Docherty AJ; Murphy G
J Cell Sci; 2000 Jun; 113 ( Pt 12)():2319-28. PubMed ID: 10825303
[TBL] [Abstract][Full Text] [Related]
8. ADAM-15 disintegrin-like domain structure and function.
Lu D; Scully M; Kakkar V; Lu X
Toxins (Basel); 2010 Oct; 2(10):2411-27. PubMed ID: 22069559
[TBL] [Abstract][Full Text] [Related]
9. ADAM 23/MDC3, a human disintegrin that promotes cell adhesion via interaction with the alphavbeta3 integrin through an RGD-independent mechanism.
Cal S; Freije JM; López JM; Takada Y; López-Otín C
Mol Biol Cell; 2000 Apr; 11(4):1457-69. PubMed ID: 10749942
[TBL] [Abstract][Full Text] [Related]
10. The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins.
Mahimkar RM; Visaya O; Pollock AS; Lovett DH
Biochem J; 2005 Jan; 385(Pt 2):461-8. PubMed ID: 15361064
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the disintegrin and cysteine-rich domains of ADAM12 with integrin alpha7beta1.
Zhao Z; Gruszczynska-Biegala J; Cheuvront T; Yi H; von der Mark H; von der Mark K; Kaufman SJ; Zolkiewska A
Exp Cell Res; 2004 Aug; 298(1):28-37. PubMed ID: 15242759
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of airway smooth muscle adhesion and migration by the disintegrin domain of ADAM-15.
Lu D; Xie S; Sukkar MB; Lu X; Scully MF; Chung KF
Am J Respir Cell Mol Biol; 2007 Oct; 37(4):494-500. PubMed ID: 17575078
[TBL] [Abstract][Full Text] [Related]
13. Metalloproteinase-like, disintegrin-like, cysteine-rich proteins MDC2 and MDC3: novel human cellular disintegrins highly expressed in the brain.
Sagane K; Ohya Y; Hasegawa Y; Tanaka I
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):93-8. PubMed ID: 9693107
[TBL] [Abstract][Full Text] [Related]
14. ADAM13 disintegrin and cysteine-rich domains bind to the second heparin-binding domain of fibronectin.
Gaultier A; Cousin H; Darribère T; Alfandari D
J Biol Chem; 2002 Jun; 277(26):23336-44. PubMed ID: 11967265
[TBL] [Abstract][Full Text] [Related]
15. Recombinant disintegrin domain of human ADAM9 inhibits migration and invasion of DU145 prostate tumor cells.
Martin AC; Cardoso AC; Selistre-de-Araujo HS; Cominetti MR
Cell Adh Migr; 2015; 9(4):293-9. PubMed ID: 26211476
[TBL] [Abstract][Full Text] [Related]
16. Adam-9 expression and regulation in human skin melanoma and melanoma cell lines.
Zigrino P; Mauch C; Fox JW; Nischt R
Int J Cancer; 2005 Oct; 116(6):853-9. PubMed ID: 15856464
[TBL] [Abstract][Full Text] [Related]
17. Accelerated wound repair in ADAM-9 knockout animals.
Mauch C; Zamek J; Abety AN; Grimberg G; Fox JW; Zigrino P
J Invest Dermatol; 2010 Aug; 130(8):2120-30. PubMed ID: 20376065
[TBL] [Abstract][Full Text] [Related]
18. ADAM disintegrin-like domain recognition by the lymphocyte integrins alpha4beta1 and alpha4beta7.
Bridges LC; Sheppard D; Bowditch RD
Biochem J; 2005 Apr; 387(Pt 1):101-8. PubMed ID: 15504110
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins alpha5beta1 and alphavbeta3 in atherosclerosis.
Al-Fakhri N; Wilhelm J; Hahn M; Heidt M; Hehrlein FW; Endisch AM; Hupp T; Cherian SM; Bobryshev YV; Lord RS; Katz N
J Cell Biochem; 2003 Jul; 89(4):808-23. PubMed ID: 12858346
[TBL] [Abstract][Full Text] [Related]
20. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
Zhong S; Khalil RA
Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
